IE 11 is not supported. For an optimal experience visit our site on another browser.

Shkreli's other drug pricing controversy


One of Martin Shkreli's companies announced plans to submit a treatment for a parasitic ailment known as Chagas disease for FDA approval next year, with plans to hike the price. The treatment can currently be obtained by doctors free through the CDC. Daisy Hernandez from Miami University and Bloomberg's Keri Geiger join to discuss.